Cargando…
Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease
BACKGROUND: Polyamine levels are intricately controlled by biosynthetic, catabolic enzymes and antizymes. The complexity suggests that minute alterations in levels lead to profound abnormalities. We described the therapeutic course for a rare syndrome diagnosed by whole exome sequencing caused by ga...
Autores principales: | Rajasekaran, Surender, Bupp, Caleb P, Leimanis-Laurens, Mara, Shukla, Ankit, Russell, Christopher, Junewick, Joseph, Gleason, Emily, VanSickle, Elizabeth A, Edgerly, Yvonne, Wittmann, Bryan M, Prokop, Jeremy W, Bachmann, André S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291972/ https://www.ncbi.nlm.nih.gov/pubmed/34282722 http://dx.doi.org/10.7554/eLife.67097 |
Ejemplares similares
-
Emerging Role of ODC1 in Neurodevelopmental Disorders and Brain Development
por: Prokop, Jeremy W., et al.
Publicado: (2021) -
Dilated coronary arteries in a 2-month-old with RIT1-associated Noonan syndrome: a case report
por: Aniol, Claudia V., et al.
Publicado: (2023) -
NAA10 variant in 38-week-gestation male patient: a case study
por: Afrin, Antara, et al.
Publicado: (2020) -
Expanding the phenotype: Four new cases and hope for treatment in Bachmann‐Bupp syndrome
por: VanSickle, Elizabeth A., et al.
Publicado: (2021) -
ETMR-18. TARGETING Lin28 IN ETMR WITH ODC1 INHIBITOR DFMO
por: Goodyke, Austin, et al.
Publicado: (2020)